These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31082662)

  • 1. "One guy goes to jail, two people are ready to take his spot": Perspectives on drug-induced homicide laws among incarcerated individuals.
    Peterson M; Rich J; Macmadu A; Truong AQ; Green TC; Beletsky L; Pognon K; Brinkley-Rubinstein L
    Int J Drug Policy; 2019 Aug; 70():47-53. PubMed ID: 31082662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "It's probably going to save my life;" attitudes towards treatment among people incarcerated in the era of fentanyl.
    Kaplowitz E; Macmadu A; Green TC; Berk J; Rich JD; Brinkley-Rubinstein L
    Drug Alcohol Depend; 2022 Mar; 232():109325. PubMed ID: 35114617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting.
    Brinkley-Rubinstein L; Peterson M; Clarke J; Macmadu A; Truong A; Pognon K; Parker M; Marshall BDL; Green T; Martin R; Stein L; Rich JD
    Drug Alcohol Depend; 2019 Dec; 205():107514. PubMed ID: 31614328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality, incarceration and cost implications of fentanyl felonization laws: A modeling study.
    Savinkina A; Jurecka C; Gonsalves G; Barocas JA
    Int J Drug Policy; 2023 Nov; 121():104175. PubMed ID: 37729682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island.
    Peterson M; Macmadu A; Truong AQ; Rich J; Pognon K; Lurie M; Clarke JG; Brinkley-Rubinstein L
    J Subst Abuse Treat; 2019 Nov; 106():73-78. PubMed ID: 31540614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
    Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL
    Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl and Drug Overdose: Perceptions of Fentanyl Risk, Overdose Risk Behaviors, and Opportunities for Intervention among People who use Opioids in Baltimore, USA.
    Latkin CA; Dayton L; Davey-Rothwell MA; Tobin KE
    Subst Use Misuse; 2019; 54(6):998-1006. PubMed ID: 30767590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.
    Bunting AM; Oser CB; Staton M; Eddens KS; Knudsen H
    Addict Sci Clin Pract; 2018 Dec; 13(1):23. PubMed ID: 30509314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Just fighting for my life to stay alive": a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories.
    Hoffman KA; Thompson E; Gaeta Gazzola M; Oberleitner LMS; Eller A; Madden LM; Marcus R; Oberleitner DE; Beitel M; Barry DT
    Addict Sci Clin Pract; 2023 Mar; 18(1):16. PubMed ID: 36944998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
    Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
    [No Abstract]   [Full Text] [Related]  

  • 13. Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers.
    Bucerius SM; Haggerty KD
    Int J Drug Policy; 2019 Sep; 71():133-138. PubMed ID: 31349150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action-focused, plain language communication for overdose prevention: A qualitative analysis of Rhode Island's overdose surveillance and information dashboard.
    Waye KM; Yedinak JL; Koziol J; Marshall BDL
    Int J Drug Policy; 2018 Dec; 62():86-93. PubMed ID: 30384027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "You Never Know What You're Getting": Opioid Users' Perceptions of Fentanyl in Southwest Pennsylvania.
    McLean K; Monnat SM; Rigg K; Sterner GE; Verdery A
    Subst Use Misuse; 2019; 54(6):955-966. PubMed ID: 30676198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health.
    Sugarman OK; Bachhuber MA; Wennerstrom A; Bruno T; Springgate BF
    PLoS One; 2020; 15(1):e0227968. PubMed ID: 31961908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use and overdose risk: documenting the perspectives of formerly incarcerated persons in the Fraser East region of BC.
    McCaughran-Contreras C; Fernando S; Sikora M; Hawkins J; Kniseley M; Snyder D; Long C; Robson J; Slaunwhite A; Salmon A
    Harm Reduct J; 2021 Jul; 18(1):77. PubMed ID: 34320983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration.
    Monico LB; Gryczynski J; Lee JD; Dusek K; McDonald R; Malone M; Sharma A; Cheng A; DeVeaugh-Geiss A; Chilcoat H
    J Subst Abuse Treat; 2021 Apr; 123():108267. PubMed ID: 33612198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
    Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
    Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.